This federal contract award was issued by the Medical Supply Chain of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $16,661.46 Delivery Order contract is for the supply of the "IMPL SYS, ALLOGRAFT GRAFTLINK CP 2" medical device, with a performance period ending on December 12, 2024. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has a significant Indefinite Delivery Contract (IDC) with the DLA valued at $471,048,172.66, allowing VA medical centers to acquire the company's innovative orthopedic technologies through task orders. The current award is not designated as a set-aside contract, indicating Arthrex's strong competitive position in the federal market for specialized medical products. Through these contract awards, Arthrex demonstrates its ability to efficiently support government healthcare systems, particularly the Department of Veterans Affairs (VA) and the Department of Defense (DoD), with a comprehensive range of advanced orthopedic solutions.
Generated 3/10/25, 9:48 AM